BioSpace News Archive

Business

Repare Therapeutics Expands Executive Leadership Team with the Appointment of Philip Herman as EVP Commercial & New Product Development

Repare Therapeutics Inc. today announced the appointment of Philip Herman as its EVP Commercial & New Product Development.

January 5, 2022
·
5 min read
IMV Inc. to Present at Two Upcoming Investor Events

IMV Inc. announced that members of IMV’s executive management team will be presenting virtually at the Biotech ShowcaseTM 2022 investor conference which will be held January 10-12 and at the H.C. Wainwright Bioconnect 2022 conference held January 10-13.

January 5, 2022
·
4 min read
Genetown

Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 Guidance

Infinity Pharmaceuticals, Inc. today provided an update on eganelisib clinical development plans and 2022 guidance.

January 5, 2022
·
6 min read
Business

PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

Ms. Bauerlein brings success in scaling to $300M+ revenue in direct-to-consumer business model and public company execution as Gelesis plans to scale Plenity® to meet growing consumer demand with its upcoming NYSE listing.

January 5, 2022
·
18 min read
BioMidwest

ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference

ENDRA Life Sciences Inc., a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022.

January 5, 2022
·
1 min read
Biotech Bay

Sierra Oncology to Present at HC Wainwright BioConnect Conference

Sierra Oncology, Inc. announced the company will participate in the 2022 HC Wainwright BioConnect Conference being held virtually from January 10-13, 2022.

January 5, 2022
·
1 min read
Business

Total Brain Licenses iSPOT-D for Depression Research to Alto Neuroscience

Total Brain, a mental health monitoring and support platform, today announced that the company will license its International Study to Predict Optimized Treatment for Depression (iSPOT-D) research data to Alto Neuroscience, a pioneer in precision psychiatric medicine.

January 5, 2022
·
2 min read
Biotech Bay

Potrero Medical to present at 40th Annual J.P. Morgan Healthcare Conference

Potrero Medical, innovator of the Accuryn Monitoring System, announced today that it has accepted an invitation to present at the 40th Annual J.P. Morgan Healthcare Conference.

January 5, 2022
·
1 min read
Can-Fite Issues Letter to Shareholders - Jan 05, 2022

Can-Fite BioPharma Ltd. issued a Letter to Shareholders from its Chief Executive Officer, Dr. Pnina Fishman.

January 5, 2022
·
8 min read
Pharm Country

TG Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference

TG Therapeutics, Inc., announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference.

January 5, 2022
·
1 min read